| S.NO. | Abbreviation | Explanation |
| 1 | 18F-DCFPyL | 2-(3-{1-carboxy-5-[(6-[(18)F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, |
| 2 | ANCA | Antineutrophilic Cytoplasmic Antibodies |
| 3 | ASCT1 | Alanine Serine Cysteine Transporter 1 |
| 4 | AUC | Area Under the Curve |
| 5 | CDK4 | Cyclin D and Cyclin-dependent Kinase 4 |
| 6 | CFTR | Cystic fibrosis transmembrane conductance regulator |
| 7 | CGRP | Calcitonin Gene-related Peptide |
| 8 | CML | Chronic Myelogenous Leukemia |
| 9 | CMV | Cytomegalovirus |
| 10 | DLBCL | Diffuse large B-cell lymphoma |
| 11 | EGFR | Epidermal Growth Factor Receptor |
| 12 | eGFR | Estimated Glomerular Filtration Rate |
| 13 | EMBRACA | Epidemiological Study of Familial Breast Cancer |
| 14 | ER | Estrogen Receptor |
| 15 | FDA | Food and Drug Administration |
| 16 | FDG | 18F-fluoro Deoxyglucose |
| 17 | GIST | Gastrointestinal Stromal tumors |
| 18 | GnRH | Gonadotropin-releasing Hormone |
| 19 | HCV | Hepatitis C Virus |
| 20 | HER1 | Human Epidermal Growth Factor Receptor 1 |
| 21 | HIF-2α | Hypoxia-Inducible Factor-2α |
| 22 | KRAS | Kirsten Rat Sarcoma Virus |
| 23 | KRAS | Kirsten Rat Sarcoma Viral Oncogene Homolog |
| 24 | LAT1, LAT3 | L-type Amino Acid Transporters |
| 25 | MAO | Monoamine Oxidase |
| 26 | MEK | Mitogen-activated Protein Kinase |
| 27 | MET | Mesenchymal Epithelial Transition |
| 28 | NF | Neurofibromas |
| 29 | NFTs | Neurofibrillary tangles |
| 30 | NO–sGC–cGMp | Nitric oxide (NO)–NO-sensitive (soluble) guanylyl cyclase (sGC)–cyclic guanosine monophosphate (cGMP) |
| 31 | NS3/4A | A non-structural protein 3 and 4a protease inhibitor |
| 32 | OX1R | Orexin Receptor Type 1 |
| 33 | PARP | Poly (ADP-ribose) Polymerase 1 |
| 34 | PARP | Poly Adenosine Diphosphate-ribose Polymerase |
| 35 | PDGFRA | Platelet-derived Growth Factor Receptor Alpha |
| 36 | PET | Positron Emission Tomography |
| 37 | PSMA | Prostate-specific Membrane Antigen |
| 38 | RET | Rational Emotive Therapy |
| 39 | TNF | Tumor Necrosis Factor |